Roche Holding AG (RHHBY) Stock Valuation: P/E Ratio and Intrinsic Value
Is Roche Holding AG stock expensive or cheap? This page shows the price-earnings ratio of Roche Holding AG for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings (FY 2025).
Earnings basis for the valuation (FY 2025)
| Revenue | 63.36 CHF bn |
|---|---|
| Net income | 13.80 CHF bn |
| Net margin | 21.8 % |
How the Roche Holding AG P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Roche Holding AG is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Roche Holding AG
What is the RHHBY P/E ratio?
The P/E ratio divides the Roche Holding AG share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of RHHBY can be compared with its own history.
Is Roche Holding AG stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of RHHBY is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Roche Holding AG?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of RHHBY as the starting point.